ロード中...
The influence of subclonal resistance mutations on targeted cancer therapy
Clinical oncology is being revolutionized by the increasing use of molecularly targeted therapies. This paradigm holds great promise for improving cancer treatment; however, allocating specific therapies to the patients who are most likely to derive a durable benefit continues to represent a conside...
保存先:
| 出版年: | Nat Rev Clin Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838548/ https://ncbi.nlm.nih.gov/pubmed/26483300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.175 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|